Udayavni Special

COVID-19: Third phase human trial of COVAXIN to commence soon


Team Udayavani, Oct 26, 2020, 11:13 AM IST

Bhubaneswar: The third phase of the human trial of the indigenous vaccine against COVID-19, COVAXIN, will commence at a private hospital here soon, an official said.

The search for a suitable vaccine for COVID-19 has almost come to the final stage, Dr E Venkata Rao, Principal Investigator in the COVAXIN human trial and Professor in the Department of Community Medicine at the Institute of Medical Sciences and SUM Hospital here said on Sunday.

IMS and SUM Hospital is among the 21 medical institutes selected across the country by the Indian Council for Medical Research (ICMR) where the third phase trial would be conducted.

The indigenous vaccine, being developed by ICMR and Bharat Biotech has received the approval of the Central Drugs Standard Control Organisation (CDSCO) for initiating the third phase trial. After completion of the first and second phase of the trial with demonstrable safety profile and immunogenicity, the large-scale efficacy trial involving thousands of volunteers has been planned now, Dr Rao said.

Dr Rao, who is the head of the Preventive and Therapeutic Clinical Trial Unit (PTCTU), said during this phase the age limit and eligibility/ screening criteria would be relaxed and several volunteers who are otherwise apparently healthy would be recruited for the trial.

Like the previous phases, half of the volunteers would receive placebo and the remaining half would be administered COVAXIN in this phase. Even health care workers would be recruited for the trial. The volunteers would be followed up over a considerable period of time to look at the efficacy of the vaccine in preventing the development of the Corona disease, he said.

Rao said there had been a huge response and enthusiasm among people who had offered themselves to be volunteers for the trial. He said persons above 18 years will be taken for the human trial.

The interested volunteers for the project could enrol themselves for the trial by registering online at www.ptctu.soa.ac under the section register for clinical trials, he said.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Indian economy contracts 7.5 pc in Q2

Poor bowling costs India opening ODI despite valiant Hardik show

CM BSY defers listing Lingayats in OBC category

Around 83 pc of Indian workforce nervous to go back to office without COVID-19 vaccine: Survey

RBI has set precedence in LVB bond write-off, will hurt other banks: Report

No govt in the world can stop farmers fighting ‘battle of truth’: Rahul

IMA ponzi scheme accused and ex-Karnataka minister R Roshan Baig hospitalised



Related Articles More

UK asks regulator to assess AZ-Oxford vaccine amid questions

K’taka COVID-19 update: 1630 new cases, 1333 discharges, 19 deaths on Nov 24

PM has indicated COVID vaccine likely to be ready soon: Yediyurappa

K’taka COVID-19 update: 1870 new cases, 1949 discharges, 17 deaths on Nov 23

Thanksgiving could be make-or-break in US virus response

MUST WATCH

Assorted flowers, fruits, and vegetables are grown in the terrace garden

Celebrating 25 Years of Laveena Masala | Since 1996 | Udayavani

Mangalore: Lashkar militants pro wall writing on on Circuit House Road | Udayavani

Madhavashankara name for Mangalore airport: Shri Sugunendra Tirtha Swamiji

Centuries-old Tuluva ritual of ‘Bhoomipuje Gaddekori’ still performed at Palthadi Village in Puttur

Latest Additions

K’taka cabinet sub-committee to examine land sale to JSW Steel

Chef Vikas Khanna’s directorial debut ‘The Last Color’ to release in India on Dec 11

India has practically achieved its pre-2020 climate action targets: Javadekar

Govt intends to formalise registration process of vintage motor vehicles

PM Modi to visit 3 cities tomorrow to review COVID-19 vaccine work

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.